Skip to content

Exercise During Chemotherapy for Patients With Hematological Malignancies

Exercise During Chemotherapy for Patients With Hematological Malignancies

Status
UNKNOWN
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00884364
Enrollment
60
Registered
2009-04-20
Start date
2009-05-31
Completion date
2011-09-30
Last updated
2009-12-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hematological Diseases, Hematological Malignancies

Keywords

Lymphoma, Leukemia, Multiple myeloma, Hodgkin´s disease, Exercise, Sport, Fatigue, Hematological neoplastic diseases

Brief summary

The trial will evaluate the effects of aerobic exercise in patients undergoing chemotherapy for the treatment of a hematological neoplastic disease.

Interventions

OTHERAerobic exercise

The patients will carry out an aerobic exercise program consisting of walking on a treadmill for 30 minutes at an intensity of 80% of the maximum heart rate. The training will be carried out three times a week.

BEHAVIORALFatigue counseling

The patients will receive a counseling regarding the causes of fatigue, how to cope with this symptom, and general recommendations about exercise. However, they will not participate at a structured exercise program.

Sponsors

Charite University, Berlin, Germany
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Masking
SINGLE (Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* Hematological malignant disease * Current chemotherapy * Understanding of written German

Exclusion criteria

* Cardiorespiratory, metabolical, osteoarticular or immunological disorders which can be aggravated by exercise * Pathological stress-ECG at recruitment

Design outcomes

Primary

MeasureTime frame
FatigueAt recruitment and after 12 weeks

Secondary

MeasureTime frame
ComplicationsAt recruitment and after 12 weeks
Physical performanceAt recruitment and after 12 weeks

Countries

Germany

Contacts

Primary ContactFernando Dimeo, MD
fernando.dimeo@charite.de+493084452098

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026